156 related articles for article (PubMed ID: 18069258)
1. [Cytogenetic and molecular basis of multiple myeloma].
Taniwaki M; Matsumoto Y
Nihon Rinsho; 2007 Dec; 65(12):2179-86. PubMed ID: 18069258
[TBL] [Abstract][Full Text] [Related]
2. [The origin and formation of chromosomal translocations in multiple myeloma].
Nemec P; Kuglík P; Hájek R
Klin Onkol; 2008; 21(2):53-8. PubMed ID: 19102212
[TBL] [Abstract][Full Text] [Related]
3. The biology of multiple myeloma.
Drach J; Kaufmann H; Urbauer E; Schreiber S; Ackermann J; Huber H
J Cancer Res Clin Oncol; 2000 Aug; 126(8):441-7. PubMed ID: 10961386
[TBL] [Abstract][Full Text] [Related]
4. Deregulation of MUM1/IRF4 by chromosomal translocation in multiple myeloma.
Iida S; Rao PH; Butler M; Corradini P; Boccadoro M; Klein B; Chaganti RS; Dalla-Favera R
Nat Genet; 1997 Oct; 17(2):226-30. PubMed ID: 9326949
[TBL] [Abstract][Full Text] [Related]
5. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
[TBL] [Abstract][Full Text] [Related]
6. Further cytogenetic characterization of multiple myeloma confirms that 14q32 translocations are a very rare event in hyperdiploid cases.
Smadja NV; Leroux D; Soulier J; Dumont S; Arnould C; Taviaux S; Taillemite JL; Bastard C
Genes Chromosomes Cancer; 2003 Nov; 38(3):234-9. PubMed ID: 14506697
[TBL] [Abstract][Full Text] [Related]
7. Cytogenetic data as a prognostic factor in multiple myeloma patients: involvement of 1p12 region an adverse prognostic factor.
Panani AD; Ferti AD; Papaxoinis C; Raptis SA; Roussos Ch
Anticancer Res; 2004; 24(6):4141-6. PubMed ID: 15736465
[TBL] [Abstract][Full Text] [Related]
8. A potential role for centrosomal deregulation within IgH translocation-positive myeloma.
Maxwell CA; Pilarski LM
Med Hypotheses; 2005; 65(5):915-21. PubMed ID: 16023302
[TBL] [Abstract][Full Text] [Related]
9. Chromosomal and genetic abnormalities in myeloma.
Joy Ho P
Clin Lab Haematol; 2002 Oct; 24(5):259-69. PubMed ID: 12358886
[TBL] [Abstract][Full Text] [Related]
10. Correlation between losses of IGH or its segments and deletions of 13q14 in t(11;14) (q13;q32) multiple myeloma.
Trakhtenbrot L; Hardan I; Koren-Michowitz M; Oren S; Yshoev G; Rechavi G; Nagler A; Amariglio N
Genes Chromosomes Cancer; 2010 Jan; 49(1):17-27. PubMed ID: 19787791
[TBL] [Abstract][Full Text] [Related]
11. Genomic characterization of the chromosomal breakpoints of t(4;14) of multiple myeloma suggests more than one possible aetiological mechanism.
Fenton JA; Pratt G; Rawstron AC; Sibley K; Rothwell D; Yates Z; Dring A; Richards SJ; Ashcroft AJ; Davies FE; Owen RG; Child JA; Morgan GJ
Oncogene; 2003 Feb; 22(7):1103-13. PubMed ID: 12592397
[TBL] [Abstract][Full Text] [Related]
12. Genetics of multiple myeloma.
Higgins MJ; Fonseca R
Best Pract Res Clin Haematol; 2005; 18(4):525-36. PubMed ID: 16026735
[TBL] [Abstract][Full Text] [Related]
13. [Fluorescence in situ hybridization identifies complex chromosomal aberrations in multiple myeloma].
Liu SY; Huang JW; Zhang J; Du HP; Jiang H; Li JY; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Dec; 24(6):685-8. PubMed ID: 18067084
[TBL] [Abstract][Full Text] [Related]
14. Duplication of chromosome arms 9q and 11q: evidence for a novel, 14q32 translocation-independent pathogenetic pathway in multiple myeloma.
Liebisch P; Scheck D; Erné SA; Wellmann A; Wendl C; Janczik S; Kolmus S; Kröber A; Einsele H; Straka C; Goldschmidt H; Benner A; Stilgenbauer S; Döhner H
Genes Chromosomes Cancer; 2005 Jan; 42(1):78-81. PubMed ID: 15390182
[TBL] [Abstract][Full Text] [Related]
15. 14q32 chromosomal translocations: a hallmark of plasma cell dyscrasias?
Avet-Loiseau H; Minvielle S; Mellerin MP; Magrangeas F; Bataille R
Hematol J; 2000; 1(5):292-4. PubMed ID: 11920205
[No Abstract] [Full Text] [Related]
16. Chromosome 14q32 translocations involving the immunoglobulin heavy chain locus in chronic lymphocytic leukaemia identify a disease subset with poor prognosis.
Cavazzini F; Hernandez JA; Gozzetti A; Russo Rossi A; De Angeli C; Tiseo R; Bardi A; Tammiso E; Crupi R; Lenoci MP; Forconi F; Lauria F; Marasca R; Maffei R; Torelli G; Gonzalez M; Martin-Jimenez P; Maria Hernandez J; Rigolin GM; Cuneo A
Br J Haematol; 2008 Aug; 142(4):529-37. PubMed ID: 18547320
[TBL] [Abstract][Full Text] [Related]
17. Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.
Avet-Loiseau H; Facon T; Grosbois B; Magrangeas F; Rapp MJ; Harousseau JL; Minvielle S; Bataille R;
Blood; 2002 Mar; 99(6):2185-91. PubMed ID: 11877296
[TBL] [Abstract][Full Text] [Related]
18. Primary extramedullary plasmacytoma: similarities with and differences from multiple myeloma revealed by interphase cytogenetics.
Bink K; Haralambieva E; Kremer M; Ott G; Beham-Schmid C; de Leval L; Peh SC; Laeng HR; Jütting U; Hutzler P; Quintanilla-Martinez L; Fend F
Haematologica; 2008 Apr; 93(4):623-6. PubMed ID: 18326524
[TBL] [Abstract][Full Text] [Related]
19. [Study on molecular cytogenetic abnormalities in multiple myeloma].
Liu SY; Li JY; Chen LJ; Huang JW; Pan JL; Qiu HR; Shen YF; Xu W; Xue YQ
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):223-6. PubMed ID: 17877196
[TBL] [Abstract][Full Text] [Related]
20. Cytogenetic manifestations of multiple myeloma heterogeneity.
Pantou D; Rizou H; Tsarouha H; Pouli A; Papanastasiou K; Stamatellou M; Trangas T; Pandis N; Bardi G
Genes Chromosomes Cancer; 2005 Jan; 42(1):44-57. PubMed ID: 15495197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]